IFS Advisors, LLC ZBIO Position History

Zenas BioPharma, Inc. • Healthcare

Quarters held

Latest value

$2K

Q3 2026

Peak value

$2K

First seen

Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

Quarter	Value	Shares	% Portfolio	Change
Q3 2026	$2K	75	—	—

Other funds holding ZBIO

Royalty Pharma Sub-Manager, LLC

$60.6M

STATE STREET CORP

$52.2M

STATE STREET CORP

$52.2M

Royalty Pharma Sub-Manager, LLC

$46.7M

Royalty Pharma Sub-Manager, LLC

$45.9M

CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM

$29.5M

STATE STREET CORP

$28.8M

CITADEL ADVISORS LLC

$26M

Other IFS Advisors, LLC positions

ETHA

ISHARES CORE S&P 500 ETF

$41.4M

ETHA

ISHARES CORE S&P 500 ETF

$34.7M

ETHA

ISHARES CORE S&P 500 ETF

$34.1M

ETHA

ISHARES CORE S&P 500 ETF

$32.1M

ETHA

ISHARES CORE S&P 500 ETF

$30.3M

ETHA

ISHARES IBONDS DEC 2026 TERM CORPORATE ETF

$23.6M

ETHA

ISHARES IBONDS DEC 2026 TERM CORPORATE ETF

$23.5M

ETHA

ISHARES IBONDS DEC 2026 TERM CORPORATE ETF

$22.7M